Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Antimicrobial Chemotherapy

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 17644532
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum β-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence

  2006cited by this paper
• Relationship of Phylogenetic Background, Biofilm Production, and Time to Detection of Growth in Blood Culture Vials with Clinical Variables and Prognosis Associated with Escherichia coli Bacteremia

  2006cited by this paper
• Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia

  2006cited by this paper
• Outcomes evaluation of patients with ESBL- and non-ESBL-producing Escherichia coli and Klebsiella species as defined by CLSI reference methods: report from the SENTRY Antimicrobial Surveillance Program.

  2006cited by this paper
• Comparison of mortality of patients with Acinetobacter baumannii bacteraemia receiving appropriate and inappropriate empirical therapy.

  2006cited by this paper
• Clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli as a cause of nosocomial infection or colonization: implications for control.

  2006cited by this paper
• Importance of Adequate Initial Antimicrobial Therapy

  2005cited by this paper
• Association between fluoroquinolone resistance and mortality in Escherichia coli and Klebsiella pneumoniae infections: the role of inadequate empirical antimicrobial therapy.

  2005cited by this paper
• Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality

  2005cited by this paper
• Nationwide Study of Escherichia coli and Klebsiella pneumoniae Producing Extended-Spectrum β-Lactamases in Spain

  2005cited by this paper
• Impact of inadequate initial antimicrobial therapy on mortality in infections due to extended-spectrum beta-lactamase-producing enterobacteriaceae: variability by site of infection.

  2005cited by this paper
• Bloodstream Infections Caused by Antibiotic-Resistant Gram-Negative Bacilli: Risk Factors for Mortality and Impact of Inappropriate Initial Antimicrobial Therapy on Outcome

  2004cited by this paper
• Risk Factors for and Clinical Outcomes of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Klebsiella pneumoniae

  2004cited by this paper
• International Prospective Study of Klebsiella pneumoniae Bacteremia: Implications of Extended-Spectrum -Lactamase Production in Nosocomial Infections

  2004cited by this paper
• Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients

  2004cited by this paper
• Bloodstream Infections Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Mortality and Treatment Outcome, with Special Emphasis on Antimicrobial Therapy

  2004cited by this paper
• Prospective observational study of bacteremic pneumococcal pneumonia: Effect of discordant therapy on mortality*

  2004cited by this paper
• [Bacteremia due to Escherichia coli: epidemiological analysis and sensitivity to antibiotics in a county hospital].

  2003cited by this paper
• Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival.

  2003cited by this paper
• Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

  2003cited by this paper
• Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella species: risk factors for colonization and impact of antimicrobial formulary interventions on colonization prevalence.

  2002cited by this paper
• Extended-Spectrum β-Lactamase–Producing Escherichia coli and Klebsiella Species: Risk Factors for Colonization and Impact of Antimicrobial Formulary Interventions on Colonization Prevalence

  2002cited by this paper
• Extended-spectrum beta-lactamase-producing Escherichiacoli and Klebsiellapneumoniae bloodstream infection: risk factors and clinical outcome

  2002cited by this paper
• Epidemiology and Prognosis of Bacteremia: A 10-y Study in a Community Hospital

  2002influential reference
• Trends in Antimicrobial Resistance among Urinary Tract Infection Isolates of Escherichia coli from Female Outpatients in the United States

  2002cited by this paper
• Multidrug-Resistant Urinary Tract Isolates ofEscherichia coli: Prevalence and Patient Demographics in the United States in 2000

  2001cited by this paper
• Extended-Spectrum β-Lactamases in the 21st Century: Characterization, Epidemiology, and Detection of This Important Resistance Threat

  2001cited by this paper
• Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study

  2001cited by this paper
• WIDESPREAD DISTRIBUTION OF URINARY TRACT INFECTIONS CAUSED BY A MULTIDRUG-RESISTANT ESCHERICHIA COLI CLONAL GROUP

  2001cited by this paper
• Widespread distribution of urinary tract infections caused by a multidrug-resistant Escherichia coli clonal group.

  2001cited by this paper
• Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

  2001cited by this paper
• The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting.

  2000cited by this paper
• Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients.

  2000cited by this paper
• Emergence and Dissemination of Quinolone-ResistantEscherichia coli in the Community

  1999cited by this paper
• The molecular and clinical epidemiology of enterobacteriaceae-producing extended-spectrum beta-lactamase in a tertiary care hospital.

  1998cited by this paper
• The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults.

  1997cited by this paper
• Detection and clinical significance of extended-spectrum beta-lactamases in a tertiary-care medical center

  1997cited by this paper
• Prognostic factors associated with improved outcome ofEscherichia coli bacteremia in a Finnish university hospital

  1997cited by this paper
• Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation.

  1996cited by this paper
• Bacteraemia due to Escherichia coli in a Danish university hospital, 1986-1990.

  1995cited by this paper
• Definitions for sepsis and organ failure.

  1992cited by this paper
• Survey ofEscherichia coli septicemia over a six-year period

  1992cited by this paper
• Bacteremia due to Escherichia coli: a study of 861 episodes.

  1990cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper

• A multi-isolate genomic approach identifies diverse Escherichia coli contamination and antimicrobial resistance carriage on retail foods

  2025cites this paper
• Phenotypic Insights Into Beta-Lactamase-Mediated Multidrug Resistance In Escherichia Coli Clinical Isolates

  2025cites this paper
• Multicenter evaluation of the QuickMIC® rapid AST system in clinical practice: impact on turnaround time compared to routine AST systems

  2025cites this paper
• Evaluation of Adjunctive Aminoglycoside Therapy Compared to β-Lactam Monotherapy in Critically Ill Patients with Gram-Negative Bloodstream Infections

  2025cites this paper
• Modelling the implementation of narrow versus broader spectrum antibiotics in the empiric treatment of E. coli bacteraemia

  2024cites this paper
• Clinical burden of invasive Escherichia coli disease among older adult patients treated in hospitals in the United States

  2023cites this paper
• Nosocomial infections and antimicrobial susceptibility patterns among patients admitted to intensive care unit of Imam Khomeini hospital in Ilam, Iran

  2023cites this paper
• Multi-Functional Chitosan Nanovesicles Loaded with Bioactive Manganese for Potential Wound Healing Applications

  2023cites this paper
• Clinical and microbiological characteristics of female patients with acute pyelonephritis who experienced urinary tract infections within the previous year.

  2023cites this paper
• Rapid phenotypic antimicrobial susceptibility testing of Gram-negative rods directly from positive blood cultures using the novel Q-linea ASTar system

  2023cites this paper
• Extended Spectrum β-Lactamase-Producing Enterobacterales of Shrimp and Salmon Available for Purchase by Consumers in Canada—A Risk Profile Using the Codex Framework

  2023cites this paper
• Empirical antibiotic therapy modalities for Enterobacteriaceae bloodstream infections in older patients and their impact on mortality: a multicentre retrospective study

  2023cites this paper
• Recent Trends in Prostate Biopsy Complication Rates and the Role of Aztreonam in Periprocedural Antimicrobial Prophylaxis—A Nationwide Population-Based Study from Korea

  2022cites this paper
• Outpatient transperineal prostate biopsy under local anaesthesia is safe, well tolerated and feasible

  2022cites this paper
• Mortality risks associated with empirical antibiotic activity in E. coli bacteraemia: an analysis of electronic health records

  2022cites this paper
• A phylogenetic approach to studying the roles of within-host evolution and between-host transmission of resistance for clinical Escherichia coli infections

  2022cites this paper
• Multicenter Evaluation of the FilmArray Blood Culture Identification 2 Panel for Pathogen Detection in Bloodstream Infections

  2022cites this paper
• Quantifying Gram-Negative Resistance to Empiric Treatment After Repeat ExpoSure To AntimicRobial Therapy (RESTART)

  2022cites this paper
• Dealing with Hidden Threats: The Antimicrobial Effect of the Embalming Process

  2022cites this paper
• E. coli bacteraemia and antimicrobial resistance following antimicrobial prescribing for urinary tract infection in the community

  2022cites this paper
• Risk factors for antimicrobial resistance in patients with Escherichia coli bacteraemia related to urinary tract infection

  2022cites this paper
• Biomarkers of sepsis in pigs, horses and cattle: from acute phase proteins to procalcitonin

  2022cites this paper
• Mortality risks associated with empirical antibiotic activity in Escherichia coli bacteraemia: an analysis of electronic health records

  2022cites this paper
• Effects of Inappropriate Administration of Empirical Antibiotics on Mortality in Adults With Bacteraemia: Systematic Review and Meta-Analysis

  2022cites this paper
• Antibiogram of Extended Spectrum Beta-Lactamase and AmpC Beta- Lactamase Producing Escherichia coli among the Patients Attending a Selected Tertiary Health Care Hospital

  2022cites this paper
• Clinical Impact of the Revised 2019 CLSI Levofloxacin Breakpoints in Patients with Enterobacterales Bacteremia

  2021cites this paper
• Impact of rapid susceptibility testing on antimicrobial therapy and clinical outcomes in Gram-negative bloodstream infections.

  2021cites this paper
• Geographic variation of antibiotic resistance in E. coli isolated from drinking water and foodstuffs in Sylhet division of Bangladesh

  2021cites this paper
• INHALE: the impact of using FilmArray Pneumonia Panel molecular diagnostics for hospital-acquired and ventilator-associated pneumonia on antimicrobial stewardship and patient outcomes in UK Critical Care—study protocol for a multicentre randomised controlled trial

  2021cites this paper
• Antimicrobial Resistance Trends of Escherichia coli Isolates from Outpatient and Inpatient Urinary Infections over a 20-Year Period

  2021cites this paper
• Co-Existence of Certain ESBLs, MBLs and Plasmid Mediated Quinolone Resistance Genes among MDR E. coli Isolated from Different Clinical Specimens in Egypt

  2021cites this paper
• Hospital-Acquired Pneumonia: The Lebanese Societies for Pulmonary, Critical Care, and Infectious Diseases and Clinical Microbiology Joint Guidelines

  2021cites this paper
• Lack of Association Between Patients Characteristics and the Carriage of Extended-spectrum β-Lactamase Producing Enterobacteriaceae in Community Settings in Blantyre, Malawi

  2021cites this paper
• Clinical Impact of Revised Ciprofloxacin Breakpoint in Patients with Urinary Tract Infections by Enterobacteriaceae

  2021cites this paper
• Evaluation of the health and healthcare system burden due to antimicrobial-resistant Escherichia coli infections in humans: a systematic review and meta-analysis

  2020cites this paper
• Impact of antibiotic timing on mortality from Gram-negative bacteraemia in an English district general hospital: the importance of getting it right every time.

  2020cites this paper
• The relationship between clinical outcomes and empirical antibiotic therapy in patients with community-onset Gram-negative bloodstream infections: a cohort study from a large teaching hospital

  2020cites this paper
• Presence of urinary symptoms in bacteremic urinary tract infection: a retrospective cohort study of Escherichia coli bacteremia

  2020cites this paper
• Differential effects of inappropriate empirical antibiotic therapy in adults with community-onset gram-positive and gram-negative aerobe bacteremia.

  2020cites this paper
• The relationship between clinical outcomes and empirical antibiotic therapy in patients with community-onset Gram-negative bloodstream infections: a cohort study from a large teaching hospital

  2020cites this paper
• Update of the treatment of nosocomial pneumonia in the ICU

  2020cites this paper
• Differential impacts of inappropriate empirical therapy on ED patients with Staphylococcus aureus and streptococci bacteremia.

  2020cites this paper
• S0950268820000941jra 1..3

  2020cites this paper
• Prognostic roles of time to positivity of blood cultures in patients with Escherichia coli bacteremia

  2020cites this paper
• Cefixime versus prulifloxacin as a prophylactic treatment for prostate biopsy: a randomized study

  2020cites this paper
• Rapid detection of carbapenem resistant Klebsiella pneumoniae directly from positive blood cultures during an outbreak in the Tuscany region in Italy

  2020cites this paper
• Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low Extended-spectrum beta-lactamase (ESBL) prevalence cohort

  2019cites this paper
• Antibiotic Resistance Profile and Diversity of Subtypes Genes in Escherichia coli Causing Bloodstream Infection in Northern Vietnam

  2019cites this paper
• A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections.

  2019cites this paper
• Clinical Risk Factors for Death Caused by Extended-Spectrum Beta-Lactamase: Producing Bacteria

  2019cites this paper
• Risk Factors for Community-Acquired Extended-Spectrum Beta-Lactamase–Producing Enterobacteriaceae Infections—A Retrospective Study of Symptomatic Urinary Tract Infections

  2019cites this paper
• University of Southern Denmark Cefuroxime compared to piperacillin/tazobactam as empirical treatment of Escherichia coli bacteremia in a low extended-spectrum beta-lactamase (ESBL) prevalence cohort Thønnings,

  2019cites this paper
• Outcome and Adequacy of Empirical Antibiotherapy in Post-Operative Peritonitis: A Retrospective Study

  2019cites this paper
• Factors that impact on the burden of Escherichia coli bacteraemia: multivariable regression analysis of 2011-2015 data from West London.

  2019cites this paper
• Parameters Affecting the Antimicrobial Properties of Cold Atmospheric Plasma Jet

  2019cites this paper
• Plasmid curing of antibiotic resistant Escherichia coli isolates from urine and stool samples

  2019influential citation
• Clinical Analysis of Bloodstream Infection of Escherichia coli in Patients with Pancreatic Cancer from 2011 to 2019

  2019cites this paper
• Evaluation of Empiric β-Lactam Susceptibility Prediction among Enterobacteriaceae by Molecular β-Lactamase Gene Testing

  2019cites this paper
• Changes in resistance among coliform bacteraemia associated with a primary care antimicrobial stewardship intervention: A population-based interrupted time series study

  2019cites this paper
• Clinical Impact of Sequence Type 131 in Adults with Community-Onset Monomicrobial Escherichia Coli Bacteremia

  2018cites this paper
• The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study

  2018cites this paper
• A review of novel technologies and techniques associated with identification of bloodstream infection etiologies and rapid antimicrobial genotypic and quantitative phenotypic determination

  2018cites this paper
• Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae.

  2018cites this paper
• Novel diagnostics of respiratory infection in the intensive care unit

  2018cites this paper
• Resistencia, virulencia y estructura poblacional de Escherichia coli uropatógeno

  2017cites this paper
• Association between dementia and reduced walking ability and 30-day mortality in patients with extended-spectrum beta-lactamase-producing Escherichia coli bacteremia

  2017cites this paper
• The Use of Bloodstream Infection Mortality to Measure the Impact of Antimicrobial Stewardship Interventions: Assessing the Evidence

  2017cites this paper
• Impact on Morbidity, Mortality, and Length of Stay of Hospital-Acquired Infections by Resistant Microorganisms

  2017cites this paper
• A Rare Case of Multiple Septic Embolism Related to Urosepsis

  2017cites this paper
• [Strategies to optimize the use of antibiotics in hospitals].

  2017cites this paper
• Anti E. coli Activity of Herbal Medicines: a Systematic Literature Review

  2017influential citation
• Timing of appropriate empirical antimicrobial administration and outcome of adults with community-onset bacteremia

  2017cites this paper
• AKTIVITAS PENGHAMBATAN BAKTERIOSIN Bifidobacterium spp. TERHADAP BAKTERI MULTI DRUGS RESISTANT (MDR) Escherichia coli DAN Klabsiella pneumonia

  2017cites this paper
• The Effect of Inadequate Initial Empiric Antimicrobial Treatment on Mortality in Critically Ill Patients with Bloodstream Infections: A Multi-Centre Retrospective Cohort Study

  2016cites this paper
• In vitro antibacterial and phytochemical potential of Aegle marmelos against multiple drug resistant (MDR) Escherichia coli

  2016cites this paper
• Antibiotic cross-resistance in the lab and resistance co-occurrence in the clinic: Discrepancies and implications in E.coli.

  2016cites this paper
• Gram-negative bacteraemia; a multi-centre prospective evaluation of empiric antibiotic therapy and outcome in English acute hospitals.

  2016cites this paper
• Bacteremic Urinary Tract Infection Caused by Multidrug-Resistant Enterobacteriaceae Are Associated With Severe Sepsis at Admission

  2016cites this paper
• Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration

  2016cites this paper
• [Factors associated with extended-spectrum betalactamases-producing organisms among patients with urinary tract infections: a prospective cohort study].

  2016cites this paper
• Clinical Outcomes and Healthcare Utilization Related to Multidrug-Resistant Gram-Negative Infections in Community Hospitals

  2016cites this paper
• Rapid identification of pathogens using molecular techniques

  2015cites this paper
• Bacteraemia caused by Escherichia coli in cancer patients at a specialist center in Pakistan.

  2015cites this paper
• Antibiotic prophylaxis with intravenous ceftriaxone and fluoroquinolone reduces infectious complications after transrectal ultrasound-guided prostatic biopsy

  2015cites this paper
• Cross-border comparison of the Dutch and German guidelines on multidrug-resistant Gram-negative microorganisms

  2015cites this paper
• Antibiotic use in residential 
aged care facilities.

  2015cites this paper
• Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study.

  2015cites this paper
• Prevalencia de la resistencia bacteriana en heridas quirúrgicas en el Hospital Central Militar

  2015cites this paper
• Clinical and economic impact of urinary tract infections caused by ESBL-producing Escherichia coli requiring hospitalization: A matched cohort study.

  2015cites this paper
• Antibiotic Restriction Might Facilitate the Emergence of Multi-drug Resistance

  2015cites this paper
• Frequency of occurrence and antimicrobial susceptibility of Gram-negative bacteremia isolates in patients with urinary tract infection: results from United States and European hospitals (2009–2011)

  2014cites this paper
• Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia

  2014cites this paper
• Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).

  2014cites this paper
• Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units.

  2014cites this paper
• Ceftolozane/tazobactam activity tested against aerobic Gram-negative organisms isolated from intra-abdominal and urinary tract infections in European and United States hospitals (2012).

  2014cites this paper
• Cancer and Infection

  2014cites this paper
• ANALYSIS OF ANTIBIOTIC USAGE IN PATIENTS WITH BACTEREMIA IN THE ICU UNIT OF DR. SOETOMO HOSPITAL SURABAYA

  2014cites this paper
• Implementation of a Computerized Decision Support System to Improve the Appropriateness of Antibiotic Therapy Using Local Microbiologic Data

  2014cites this paper
• Relevancia de los factores de virulencia de escherichia coli en el desarrollo de síndrome de respuesta inflamatoria sistémica y mortalidad en pacientes con bacteriemia por e. coli

  2014cites this paper
• Ertapenem prophylaxis reduces sepsis after transrectal biopsy of the prostate

  2014cites this paper